181 related articles for article (PubMed ID: 35895090)
1. Inhibition of Metastasis by Polypyridyl Ru(II) Complexes through Modification of Cancer Cell Adhesion -
Gurgul I; Janczy-Cempa E; Mazuryk O; Lekka M; Łomzik M; Suzenet F; Gros PC; Brindell M
J Med Chem; 2022 Aug; 65(15):10459-10470. PubMed ID: 35895090
[TBL] [Abstract][Full Text] [Related]
2. Impact of Polypyridyl Ru Complexes on Angiogenesis-Contribution to Their Antimetastatic Activity.
Gurgul I; Mazuryk O; Stachyra K; Olszanecki R; Lekka M; Łomzik M; Suzenet F; Gros PC; Brindell M
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887054
[TBL] [Abstract][Full Text] [Related]
3. The biological effect of the nitroimidazole derivative of a polypyridyl ruthenium complex on cancer and endothelial cells.
Mazuryk O; Suzenet F; Kieda C; Brindell M
Metallomics; 2015 Mar; 7(3):553-66. PubMed ID: 25711770
[TBL] [Abstract][Full Text] [Related]
4. Improving Cytotoxicity against Breast Cancer Cells by Using Mixed-Ligand Ruthenium(II) Complexes of 2,2'-Bipyridine, Amino Acid, and Nitric Oxide Derivatives as Potential Anticancer Agents.
Gaspari APS; da Silva RS; Carneiro ZA; de Carvalho MR; Carvalho I; Pernomian L; Ferreira LP; Ramos LCB; de Souza GA; Formiga ALB
Anticancer Agents Med Chem; 2021; 21(12):1602-1611. PubMed ID: 33081686
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Matrix Metalloproteinases and Cancer Cell Detachment by Ru(II) Polypyridyl Complexes Containing 4,7-Diphenyl-1,10-phenanthroline Ligands-New Candidates for Antimetastatic Agents.
Gajda-Morszewski P; Gurgul I; Janczy-Cempa E; Mazuryk O; Łomzik M; Brindell M
Pharmaceuticals (Basel); 2021 Oct; 14(10):. PubMed ID: 34681238
[TBL] [Abstract][Full Text] [Related]
6. Unexplored features of Ru(ii) polypyridyl complexes - towards combined cytotoxic and antimetastatic activity.
Gurgul I; Mazuryk O; Łomzik M; Gros PC; Rutkowska-Zbik D; Brindell M
Metallomics; 2020 May; 12(5):784-793. PubMed ID: 32227043
[TBL] [Abstract][Full Text] [Related]
7. The anti-cancer effect of series of strained photoactivatable Ru(II) polypyridyl complexes on non-small-cell lung cancer and triple negative breast cancer cells.
Fayad C; Audi H; Khnayzer RS; Daher CF
J Biol Inorg Chem; 2021 Feb; 26(1):43-55. PubMed ID: 33221954
[TBL] [Abstract][Full Text] [Related]
8. 2-Nitroimidazole-ruthenium polypyridyl complex as a new conjugate for cancer treatment and visualization.
Mazuryk O; Maciuszek M; Stochel G; Suzenet F; Brindell M
J Inorg Biochem; 2014 May; 134():83-91. PubMed ID: 24571925
[TBL] [Abstract][Full Text] [Related]
9. Anticancer activity of ruthenium(II) plumbagin complexes with polypyridyl as ancillary ligands via inhibiting energy metabolism and GADD45A-mediated cell cycle arrest.
Li YL; Zhu XM; Chen NF; Chen ST; Yang Y; Liang H; Chen ZF
Eur J Med Chem; 2022 Jun; 236():114312. PubMed ID: 35421660
[TBL] [Abstract][Full Text] [Related]
10. In Vitro and In Silico Screening of Benzimidazole-Based Ruthenium(II) Complexes as Potent ALK Inhibitor for Cancer Prevention.
Karthick K; Abinaya M; Shankar T; Swarnalatha K
Appl Biochem Biotechnol; 2023 Dec; 195(12):7397-7413. PubMed ID: 37000352
[TBL] [Abstract][Full Text] [Related]
11. A lysosome-targeted ruthenium(II) polypyridyl complex as photodynamic anticancer agent.
Chen J; Tao Q; Wu J; Wang M; Su Z; Qian Y; Yu T; Wang Y; Xue X; Liu HK
J Inorg Biochem; 2020 Sep; 210():111132. PubMed ID: 32569884
[TBL] [Abstract][Full Text] [Related]
12. Development of four ruthenium polypyridyl complexes as antitumor agents: Design, biological evaluation and mechanism investigation.
Jiang GB; Zhang WY; He M; Gu YY; Bai L; Wang YJ; Yi QY; Du F
J Inorg Biochem; 2020 Jul; 208():111104. PubMed ID: 32485635
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, Characterization, Cytotoxic Activity, and Metabolic Studies of Ruthenium(II) Polypyridyl Complexes Containing Flavonoid Ligands.
Munteanu AC; Notaro A; Jakubaszek M; Cowell J; Tharaud M; Goud B; Uivarosi V; Gasser G
Inorg Chem; 2020 Apr; 59(7):4424-4434. PubMed ID: 32191449
[TBL] [Abstract][Full Text] [Related]
14. 8-Hydroxyquinoline-modified ruthenium(II) polypyridyl complexes for JMJD inhibition and photodynamic antitumor therapy.
Ma X; Lu J; Yang P; Zhang Z; Huang B; Li R; Ye R
Dalton Trans; 2022 Sep; 51(36):13902-13909. PubMed ID: 36040403
[TBL] [Abstract][Full Text] [Related]
15. Unravelling the role of [Ru(bpy)
Paul L; Enkhbold K; Robinson S; Aye TT; Chung Y; Harrison DP; Pollock JA; Norris MR
J Inorg Biochem; 2022 Oct; 235():111930. PubMed ID: 35841722
[TBL] [Abstract][Full Text] [Related]
16. New ruthenium compounds bearing semicarbazone 2-formylopyridine moiety: Playing with auxiliary ligands for tuning the mechanism of biological activity.
Łomzik M; Mazuryk O; Rutkowska-Zbik D; Stochel G; Gros PC; Brindell M
J Inorg Biochem; 2017 Oct; 175():80-91. PubMed ID: 28738277
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and characterization of polypyridine ruthenium(II) complexes and anticancer efficacy studies in vivo and in vitro.
Liang L; Wu X; Shi C; Wen H; Wu S; Chen J; Huang C; Wang Y; Liu Y
J Inorg Biochem; 2022 Nov; 236():111963. PubMed ID: 35988387
[TBL] [Abstract][Full Text] [Related]
18. Systematic evaluation of the antitumor activity of three ruthenium polypyridyl complexes.
Jiang GB; Zhang WY; He M; Gu YY; Bai L; Wang YJ; Yi QY; Du F
J Inorg Biochem; 2021 Dec; 225():111616. PubMed ID: 34555601
[TBL] [Abstract][Full Text] [Related]
19. Spectral characteristics, DNA-binding and cytotoxicity of two functional Ru(II) mixed-ligand complexes.
Tan L; Shen J; Liu J; Zeng L; Jin L; Weng C
Dalton Trans; 2012 Apr; 41(15):4575-87. PubMed ID: 22358386
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of ruthenium polypyridine complexes with benzyloxyl groups and their antibacterial activities against Staphylococcus aureus.
Wang R; Wei M; Wang X; Chen Y; Xiong Y; Cheng J; Tan Y; Liao X; Wang J
J Inorg Biochem; 2022 Nov; 236():111954. PubMed ID: 35988386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
